EVER Pharma Product List
Product Description
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Categories
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from EVER Pharma (4)
-
Product Cabazitaxel EVER Pharma: 45mg/4.5ml + 50mg/5ml + 60mg/60ml - Single liquid vial
Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes covering the common range of patient specifi c doses for economy and convenience Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t f... -
Product CDMO: Contract Development
EVER is a leader in pharmaceutical development
Our end-to-end service covers every aspect of pharmaceutical development, from API selection to final process validation and quality assurance, with the highest level of expertise.
With ‘state of the art’ labs in Unterach ... -
Product CDMO: Contract Manufacturing
EVER Pharma is a specialist in the manufacture of complex injectable products such as low oxygen formulations, crystal suspensions and oily solutions. This includes many highly active substances such as narcotics, hormones and cytotoxics.
Our state-of-the-art facility utilizes the latest innovatio... -
Product EVER Pharma: Product Portfolio
Our products include: • Atosiban • Cabazitaxel • Cerbrium • Cerebrolysin • Dacepton/Apomorphine • Dexemedetomidine • Docetaxel • Fulvestrant • MemoProve • Oxytocin • Paclitaxel • Pemetrexed • Tachyben • Terlipressin • Trabectedin • Eribulin
EVER Pharma resources (2)
-
News EVER Pharma gains EU Marketing Authorization for Trabectedin
EVER Pharma announces the EU-wide marketing authorization of Trabectedin (in 0.25MG and 1MG vial sizes) for the treatment of advanced soft tissue sarcoma and ovarian cancer -
Technical Data EVER Pharma: Product list of speciality injectables
EVER Pharma's products include: Atosiban -- 7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance